The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

For centuries, royalty has been synonymous with duty, tradition, and power. However, not everyone born into or married into a ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Researchers at Keele University have published the first investigation into the variation in the chemical makeup of ...

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.

In patients with biochemical recurrence after prostate cancer surgery, the optimal duration of hormone therapy after salvage radiation therapy has been debated.

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.

Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval ...

Prostatype Genomics announces that previously communicated positive results from a Spanish multicentre study with Prostatype®, have now been confirmed in a scientific journal. The study included 93 pa ...